Memory immune responses against pandemic (h1n1) 2009 influenza virus induced by a whole particle vaccine in cynomolgus monkeys carrying mafa-a1*052:02

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Arikata, Masahiko ^a   Itoh, Yasushi ^a   Okamatsu, Masatoshi ^b   Maeda, Toshinaga ^a   Shiina, Takashi ^d   Tanaka, Keiko ^d   Suzuki, Shingo ^d   Nakayama, Misako ^a   Sakoda, Yoshihiro ^b   Ishigaki, Hirohito ^a   Takada, Ayato ^c   Ishida, Hideaki ^a   Soda, Kosuke ^b   van Pham, Loi ^a   Tsuchiya, Hideaki ^a   Nakamura, Shinichiro ^a   Torii, Ryuzo ^a   Shimizu, Takeshi ^a   Inoko, Hidetoshi ^d   Ohkubo, Iwao ^a   Kida, Hiroshi ^b,c   Ogasawara, Kazumasa ^a   more..

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

^d TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INFLUENZA VACCINE; INTERLEUKIN 2; INTERLEUKIN 4; MAFA A1 PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NEUTRALIZING ANTIBODY; NUCLEOPROTEIN; UNCLASSIFIED DRUG; COMPLEMENTARY DNA; CYTOKINE; PRIMER DNA; VIRUS ANTIBODY;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; BODY TEMPERATURE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CROSS REACTION; CYTOKINE PRODUCTION; FEMALE; IMMUNOLOGICAL MEMORY; INFLUENZA VIRUS A H1N1; MACACA; NONHUMAN; NUCLEOTIDE SEQUENCE; VIRUS NEUTRALIZATION; VIRUS STRAIN; AMINO ACID SEQUENCE; ANIMAL; BLOOD; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE; GENETIC TRANSFECTION; GENETICS; IMMUNOLOGY; LIQUID CHROMATOGRAPHY; MACACA FASCICULARIS; MOLECULAR GENETICS; ORTHOMYXOVIRUS INFECTION; POLYMERASE CHAIN REACTION; SERODIAGNOSIS; TANDEM MASS SPECTROMETRY;

INFLUENZA A VIRUS; MACACA; MACACA FASCICULARIS; ORTHOMYXOVIRIDAE;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, VIRAL; BODY TEMPERATURE; CHROMATOGRAPHY, LIQUID; CYTOKINES; DNA PRIMERS; DNA, COMPLEMENTARY; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENES, MHC CLASS I; IMMUNOLOGIC MEMORY; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; MACACA FASCICULARIS; MOLECULAR SEQUENCE DATA; NEUTRALIZATION TESTS; ORTHOMYXOVIRIDAE INFECTIONS; POLYMERASE CHAIN REACTION; TANDEM MASS SPECTROMETRY; TRANSFECTION;

EID: 84862071868     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037220     Document Type: Article

References (54)

1. Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, et al. (2009) Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 360: 2605-2615.
2. Itoh Y, Shinya K, Kiso M, Watanabe T, Sakoda Y, et al. (2009) In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 460: 1021-1025.
3. Soto-Abraham MV, Soriano-Rosas J, Diaz-Quinonez A, Silva-Pereyra J, Vazquez-Hernandez P, et al. (2009) Pathological changes associated with the 2009 H1N1 virus. N Engl J Med 361: 2001-2003.
4. Writing committee of the WHO consultation on clinical aspects of pandemic (H1N1) 2009 influenza (2009) Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med 362: 1708-1719.
5. Herfst S, van den Brand JM, Schrauwen EJ, de Wit E, Munster VJ, et al. (2010) Pandemic 2009 H1N1 influenza virus causes diffuse alveolar damage in cynomolgus macaques. Vet Pathol 47: 1040-1047.
6. Safronetz D, Rockx B, Feldmann F, Belisle SE, Palermo RE, et al. (2011) Pandemic swine-origin H1N1 influenza A virus isolates show heterogeneous virulence in macaques. J Virol 85: 1214-1223.
7. Kitano M, Itoh Y, Kodama M, Ishigaki H, Nakayama M, et al. (2010) Establishment of a cynomolgus macaque model of influenza B virus infection. Virology 407: 178-184.
8. Kida H, Sakoda Y, (2006) Library of influenza virus strains for vaccine and diagnostic use against highly pathogenic avian influenza and human pandemics. Dev Biol (Basel) 124: 69-72.
9. Itoh Y, Ozaki H, Tsuchiya H, Okamoto K, Torii R, et al. (2008) A vaccine prepared from a non-pathogenic H5N1 avian influenza virus strain confers protective immunity against highly pathogenic avian influenza virus infection in cynomolgus macaques. Vaccine 26: 562-572.
10. Itoh Y, Ozaki H, Ishigaki H, Sakoda Y, Nagata T, et al. (2010) Subcutaneous inoculation of a whole virus particle vaccine prepared from a non-pathogenic virus library induces protective immunity against H7N7 highly pathogenic avian influenza virus in cynomolgus macaques. Vaccine 28: 780-789.
11. Samad RA, Nomura N, Tsuda Y, Manzoor R, Kajihara M, et al. (2011) A vaccine prepared from a non-pathogenic H5N1 influenza virus strain from the influenza virus library conferred protective immunity to chickens against the challenge with antigenically drifted highly pathogenic avian influenza virus. Jpn J Vet Res 59: 23-29.
12. McMichael AJ, Gotch F, Cullen P, Askonas B, Webster RG, (1981) The human cytotoxic T cell response to influenza A vaccination. Clin Exp Immunol 43: 276-284.
13. Greenbaum JA, Kotturi MF, Kim Y, Oseroff C, Vaughan K, et al. (2009) Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population. Proc Natl Acad Sci U S A 106: 20365-20370.
14. Hancock K, Veguilla V, Lu X, Zhong W, Butler EN, et al. (2009) Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 361: 1945-1952.
15. Sidney J, Dzuris JL, Newman MJ, Johnson RP, Kaur A, et al. (2000) Definition of the Mamu A*01 peptide binding specificity: application to the identification of wild-type and optimized ligands from simian immunodeficiency virus regulatory proteins. J Immunol 165: 6387-6399.
16. Uda A, Tanabayashi K, Fujita O, Hotta A, Terao K, et al. (2005) Identification of the MHC class I B locus in cynomolgus monkeys. Immunogenetics 57: 189-197.
17. Rapin N, Hoof I, Lund O, Nielsen M, (2008) MHC motif viewer. Immunogenetics 60: 759-765.
18. Burwitz BJ, Pendley CJ, Greene JM, Detmer AM, Lhost JJ, et al. (2009) Mauritian cynomolgus macaques share two exceptionally common major histocompatibility complex class I alleles that restrict simian immunodeficiency virus-specific CD8+ T cells. J Virol 83: 6011-6019.
19. Hosken NA, Bevan MJ, (1990) Defective presentation of endogenous antigen by a cell line expressing class I molecules. Science 248: 367-370.
20. Attaya M, Jameson S, Martinez CK, Hermel E, Aldrich C, et al. (1992) Ham-2 corrects the class I antigen-processing defect in RMA-S cells. Nature 355: 647-649.
21. Hofmann S, Gluckmann M, Kausche S, Schmidt A, Corvey C, et al. (2005) Rapid and sensitive identification of major histocompatibility complex class I-associated tumor peptides by Nano-LC MALDI MS/MS. Mol Cell Proteomics 4: 1888-1897.
22. Shiino T, Okabe N, Yasui Y, Sunagawa T, Ujike M, et al. (2010) Molecular evolutionary analysis of the influenza A(H1N1)pdm, May-September, 2009: temporal and spatial spreading profile of the viruses in Japan. PLoS One 5: e11057.
23. Nishiura H, Kamiya K, (2011) Fever screening during the influenza (H1N1-2009) pandemic at Narita International Airport, Japan. BMC Infect Dis 11: 111.
24. World Health Organization (2005) Influenza vaccines: WHO position paper. Weekly Epidemiology Record 33: 279-287.
25. Yoshino N, Ami Y, Terao K, Tashiro F, Honda M, (2000) Upgrading of flow cytometric analysis for absolute counts, cytokines and other antigenic molecules of cynomolgus monkeys (Macaca fascicularis) by using anti-human cross-reactive antibodies. Exp Anim 49: 97-110.
26. Townsend AR, Rothbard J, Gotch FM, Bahadur G, Wraith D, et al. (1986) The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell 44: 959-968.
27. Kang SM, Yoo DG, Kim MC, Song JM, Park MK, et al. (2011) MyD88 plays an essential role in inducing B cells capable of differentiating into antibody secreting cells after vaccination. J Virol 85: 11391-11400.
28. Sawai T, Itoh Y, Ozaki H, Isoda N, Okamoto K, et al. (2008) Induction of cytotoxic T-lymphocyte and antibody responses against highly pathogenic avian influenza virus infection in mice by inoculation of apathogenic H5N1 influenza virus particles inactivated with formalin. Immunology 124: 155-165.
29. Prieto-Lara E, Llanos-Mendez A, (2010) Safety and immunogenicity of prepandemic H5N1 influenza vaccines: a systematic review of the literature. Vaccine 28: 4328-4334.
30. Hoft DF, Babusis E, Worku S, Spencer CT, Lottenbach K, et al. (2011) Live and inactivated influenza vaccines induce similar humoral responses, but only live vaccines induce diverse T-cell responses in young children. J Infect Dis 204: 845-853.
31. Rueda P, Martinez-Torrecuadrada JL, Sarraseca J, Sedlik C, del Barrio M, et al. (1999) Engineering parvovirus-like particles for the induction of B-cell, CD4+ and CTL responses. Vaccine 18: 325-332.
32. Moron VG, Rueda P, Sedlik C, Leclerc C, (2003) In vivo, dendritic cells can cross-present virus-like particles using an endosome-to-cytosol pathway. J Immunol 171: 2242-2250.
33. Song JM, Hossain J, Yoo DG, Lipatov AS, Davis CT, et al. (2010) Protective immunity against H5N1 influenza virus by a single dose vaccination with virus-like particles. Virology 405: 165-175.
34. Saurwein-Teissl M, Zisterer K, Schmitt TL, Gluck R, Cryz S, et al. (1998) Whole virus influenza vaccine activates dendritic cells (DC) and stimulates cytokine production by peripheral blood mononuclear cells (PBMC) while subunit vaccines support T cell proliferation. Clin Exp Immunol 114: 271-276.
35. Corbett NP, Blimkie D, Ho KC, Cai B, Sutherland DP, et al. (2010) Ontogeny of Toll-like receptor mediated cytokine responses of human blood mononuclear cells. PLoS One 5: e15041.
36. Koyama S, Aoshi T, Tanimoto T, Kumagai Y, Kobiyama K, et al. (2010) Plasmacytoid dendritic cells delineate immunogenicity of influenza vaccine subtypes. Sci Transl Med 2: 25ra24.
37. Keller SA, Schwarz K, Manolova V, von Allmen CE, Kinzler MG, et al. (2010) Innate signaling regulates cross-priming at the level of DC licensing and not antigen presentation. Eur J Immunol 40: 103-112.
38. Oh JZ, Kurche JS, Burchill MA, Kedl RM, (2011) TLR7 enables cross-presentation by multiple dendritic cell subsets through a type I IFN-dependent pathway. Blood 118: 3028-3038.
39. Ruprecht CR, Lanzavecchia A, (2006) Toll-like receptor stimulation as a third signal required for activation of human naive B cells. Eur J Immunol 36: 810-816.
40. Kasturi SP, Skountzou I, Albrecht RA, Koutsonanos D, Hua T, et al. (2011) Programming the magnitude and persistence of antibody responses with innate immunity. Nature 470: 543-547.
41. Finkelman FD, Katona IM, Mosmann TR, Coffman RL, (1988) IFN-γ regulates the isotypes of Ig secreted during in vivo humoral immune responses. J Immunol 140: 1022-1027.
42. Kawano Y, Noma T, Yata J, (1994) Regulation of human IgG subclass production by cytokines. IFN-γ and IL-6 act antagonistically in the induction of human IgG1 but additively in the induction of IgG2. J Immunol 153: 4948-4958.
43. Takada A, Matsushita S, Ninomiya A, Kawaoka Y, Kida H, (2003) Intranasal immunization with formalin-inactivated virus vaccine induces a broad spectrum of heterosubtypic immunity against influenza A virus infection in mice. Vaccine 21: 3212-3218.
44. Khurana S, Wu J, Verma N, Verma S, Raghunandan R, et al. (2011) H5N1 virus-like particle vaccine elicits cross-reactive neutralizing antibodies in humans that preferentially bind to oligomeric form of influenza hemagglutinin. J Virol 85: 10945-10954.
45. Bright RA, Carter DM, Daniluk S, Toapanta FR, Ahmad A, et al. (2007) Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin. Vaccine 25: 3871-3878.
46. Valkenburg SA, Gras S, Guillonneau C, La Gruta NL, Thomas PG, et al. (2010) Protective efficacy of cross-reactive CD8+ T cells recognising mutant viral epitopes depends on peptide-MHC-I structural interactions and T cell activation threshold. PLoS Pathog 6: e1001039.
47. Weinfurter JT, Brunner K, Capuano SV 3rd, Li C, Broman KW, et al. (2011) Cross-Reactive T Cells Are Involved in Rapid Clearance of 2009 Pandemic H1N1 Influenza Virus in Nonhuman Primates. PLoS Pathog 7: e1002381.
48. Ito T, Couceiro JN, Kelm S, Baum LG, Krauss S, et al. (1998) Molecular basis for the generation in pigs of influenza A viruses with pandemic potential. J Virol 72: 7367-7373.
49. Kitano M, Itoh Y, Kodama M, Ishigaki H, Nakayama M, et al. (2011) Efficacy of single intravenous injection of peramivir against influenza B virus infection in ferrets and cynomolgus macaques. Antimicrob Agents Chemother 55: 4961-4970.
50. Kida H, Webster RG, Yanagawa R, (1983) Inhibition of virus-induced hemolysis with monoclonal antibodies to different antigenic areas on the hemagglutinin molecule of A/seal/Massachusetts/1/80 (H7N7) influenza virus. Arch Virol 76: 91-99.
51. Kita YF, Hosomichi K, Kohara S, Itoh Y, Ogasawara K, et al. (2009) MHC class I A loci polymorphism and diversity in three Southeast Asian populations of cynomolgus macaque. Immunogenetics 61: 635-648.
52. Takamiya Y, Schonbach C, Nokihara K, Yamaguchi M, Ferrone S, et al. (1994) HLA-B*3501-peptide interactions: role of anchor residues of peptides in their binding to HLA-B*3501 molecules. Int Immunol 6: 255-261.
53. Ohno S, Moriya O, Yoshimoto T, Hayashi H, Akatsuka T, et al. (2006) Immunogenic variation between multiple HLA-A*0201-restricted, Hepatitis C Virus-derived epitopes for cytotoxic T lymphocytes. Viral Immunol 19: 458-467.
54. Shimizu Y, Geraghty DE, Koller BH, Orr HT, DeMars R, (1988) Transfer and expression of three cloned human non-HLA-A,B,C class I major histocompatibility complex genes in mutant lymphoblastoid cells. Proc Natl Acad Sci USA 85: 227-231.